How prevalent is osteoporosis in a high-risk subgroup? A multicenter study of postmenopausal women hospitalized for fractures in China

高危人群中骨质疏松症的患病率有多高?一项针对中国因骨折住院的绝经后妇女的多中心研究

阅读:1

Abstract

INTRODUCTION: Osteoporosis is the principal underlying cause of fractures in postmenopausal women. Despite consensus on the importance of secondary prevention, a profound treatment gap exists, partly due to the lack of precise data on disease burden in the highest-risk population. This study aimed to determine the prevalence of osteoporosis and its associated factors specifically among postmenopausal women hospitalized for fractures, a critical evidence gap in orthopedic practice. METHODS: We conducted a multicenter cross-sectional study across eight tertiary hospitals in China between March and May 2024. Eligible participants were postmenopausal women hospitalized for fractures who met predefined inclusion and exclusion criteria. All participating surgeons completed standardized protocol training for data collection, and each study site contributed up to 160 cases. RESULTS: The study included 822 postmenopausal women (mean age: 68.9 ± 10.7 years), with an overall osteoporosis prevalence of 76.9% (95% CI: 73.8%–79.7%). The prevalence was significantly higher among those with longer menopause duration (per year: adjusted odds ratio [aOR] = 1.08, 95% CI: 1.04-1.13, P < 0.001), vertebral fractures (vs patellar, tibiofibular, or ankle fractures: aOR = 3.16, 95% CI: 1.84-5.45, P < 0.001), and a history of fractures (aOR = 8.53, 95% CI: 2.56-52.94, P < 0.001). CONCLUSIONS: This study reveals an alarmingly high prevalence (76.9%) of osteoporosis among postmenopausal women hospitalized for fractures in China, identifying prolonged menopause, vertebral fractures, and recent fracture history as key risk profiles. The findings mandate a shift in inpatient fracture care. They provide compelling evidence for implementing universal bone health assessment, specifically through in-hospital systems like Fracture Liaison Services (FLS), as a standard of care for this high-risk population to mitigate subsequent fracture risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-026-09517-2.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。